Advanced search

Authors whose works are in public domain in at least one jurisdiction

List of works by Armando Santoro

1-50 of 508 results

View this query on the Wikidata Query Service
Sorafenib in advanced hepatocellular carcinoma

scientific article (publication date: 24 July 2008)
Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer

scientific article (publication date: 22 July 2004)
Ceritinib in ALK-rearranged non-small-cell lung cancer

scientific article
Reduced cardiotoxicity and comparable efficacy in a phase III trial of pegylated liposomal doxorubicin HCl (CAELYX/Doxil) versus conventional doxorubicin for first-line treatment of metastatic breast cancer

scientific article
Phase II study of sorafenib in patients with advanced hepatocellular carcinoma

scientific article published on 14 August 2006
Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: subanalyses of a phase III trial

scientific article published on 19 June 2012
Tivantinib for second-line treatment of advanced hepatocellular carcinoma: a randomised, placebo-controlled phase 2 study.

scientific article
Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I-II study.

scientific article published in April 2009
Nivolumab for classical Hodgkin's lymphoma after failure of both autologous stem-cell transplantation and brentuximab vedotin: a multicentre, multicohort, single-arm phase 2 trial

scientific article
Increased MET gene copy number negatively affects survival of surgically resected non-small-cell lung cancer patients

scientific article published on 2 March 2009
Effect of everolimus on survival in advanced hepatocellular carcinoma after failure of sorafenib: the EVOLVE-1 randomized clinical trial

scientific article
Prognostic factors for the outcome of chemotherapy in advanced soft tissue sarcoma: an analysis of 2,185 patients treated with anthracycline-containing first-line regimens--a European Organization for Research and Treatment of Cancer Soft Tissue and

scientific article
A randomized double-blind multicenter phase III study of fixed-dose single-administration pegfilgrastim versus daily filgrastim in patients receiving myelosuppressive chemotherapy

scientific article
Doxorubicin versus CYVADIC versus doxorubicin plus ifosfamide in first-line treatment of advanced soft tissue sarcomas: a randomized study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group

scientific article
SEARCH: a phase III, randomized, double-blind, placebo-controlled trial of sorafenib plus erlotinib in patients with advanced hepatocellular carcinoma.

scientific article published on 29 December 2014
Activity and safety of ceritinib in patients with ALK-rearranged non-small-cell lung cancer (ASCEND-1): updated results from the multicentre, open-label, phase 1 trial

scientific article
Sorafenib: a review of its use in advanced hepatocellular carcinoma

scientific article (publication date: 2009)
Identifying and targeting ROS1 gene fusions in non-small cell lung cancer

scientific article
A randomized study of lung cancer screening with spiral computed tomography: three-year results from the DANTE trial

scientific article
Clinical safety and activity of pembrolizumab in patients with malignant pleural mesothelioma (KEYNOTE-028): preliminary results from a non-randomised, open-label, phase 1b trial.

scientific article
Phase III, randomized, double-blind, placebo-controlled trial of gemcitabine/cisplatin alone or with sorafenib for the first-line treatment of advanced, nonsquamous non-small-cell lung cancer

scientific article published on 30 July 2012
Phase III Multinational, Randomized, Double-Blind, Placebo-Controlled Study of Tivantinib (ARQ 197) Plus Erlotinib Versus Erlotinib Alone in Previously Treated Patients With Locally Advanced or Metastatic Nonsquamous Non-Small-Cell Lung Cancer.

scientific article published on 13 July 2015
EGFR FISH assay predicts for response to cetuximab in chemotherapy refractory colorectal cancer patients

scientific article published on 31 October 2007
Usefulness of alpha-fetoprotein response in patients treated with sorafenib for advanced hepatocellular carcinoma.

scientific article
CD3+ cells at the invasive margin of deeply invading (pT3–T4) colorectal cancer and risk of post-surgical metastasis: a longitudinal study

scientific article published on 03 August 2009
Flow sorting and exome sequencing reveal the oncogenome of primary Hodgkin and Reed-Sternberg cells.

scientific article
Primary resistance to cetuximab therapy in EGFR FISH-positive colorectal cancer patients

scientific article published on 24 June 2008
Regorafenib as second-line therapy for intermediate or advanced hepatocellular carcinoma: multicentre, open-label, phase II safety study

scientific article published on 25 June 2013
Reduced likelihood of metastases in patients with microsatellite-unstable colorectal cancer

scientific article published on 01 July 2007
Durvalumab as third-line or later treatment for advanced non-small-cell lung cancer (ATLANTIC): an open-label, single-arm, phase 2 study.

scientific article published on 12 March 2018
Early Prediction of Response to Tyrosine Kinase Inhibitors by Quantification of EGFR Mutations in Plasma of NSCLC Patients

scientific article published on 20 August 2015
Randomised, placebo-controlled, double-blind, parallel-group phase III study evaluating aflibercept in patients receiving first-line treatment with gemcitabine for metastatic pancreatic cancer

scientific article published on 30 April 2013
A randomized phase III study comparing adjuvant 5-fluorouracil/folinic acid with FOLFIRI in patients following complete resection of liver metastases from colorectal cancer

scientific article published on 30 June 2009
Brentuximab Vedotin with Chemotherapy for Stage III or IV Hodgkin's Lymphoma

scientific article published on 10 December 2017
Allogeneic transplantation improves the overall and progression-free survival of Hodgkin lymphoma patients relapsing after autologous transplantation: a retrospective study based on the time of HLA typing and donor availability

scientific article published on 10 March 2010
Long-Term Follow-up Results of the DANTE Trial, a Randomized Study of Lung Cancer Screening with Spiral Computed Tomography

scientific article
Nivolumab for Relapsed/Refractory Classic Hodgkin Lymphoma After Failure of Autologous Hematopoietic Cell Transplantation: Extended Follow-Up of the Multicohort Single-Arm Phase II CheckMate 205 Trial

article
Assessment of EGFR mutations in circulating tumor cell preparations from NSCLC patients by next generation sequencing: toward a real-time liquid biopsy for treatment

scientific article
An open-label, single-arm study assessing safety and efficacy of panitumumab in patients with metastatic colorectal cancer refractory to standard chemotherapy

scientific article published on 4 September 2007
Ifosfamide, gemcitabine, and vinorelbine: a new induction regimen for refractory and relapsed Hodgkin's lymphoma

scientific article
The effect of body mass index on overall and disease-free survival in node-positive breast cancer patients treated with docetaxel and doxorubicin-containing adjuvant chemotherapy: the experience of the BIG 02-98 trial

scientific article published in January 2010
Phase III trial of pemetrexed plus best supportive care compared with best supportive care in previously treated patients with advanced malignant pleural mesothelioma

scientific article published in April 2008
Phase II study of pemetrexed plus carboplatin in malignant pleural mesothelioma

scientific article published on 01 March 2006
Safety and efficacy of allogeneic hematopoietic stem cell transplant after PD-1 blockade in relapsed/refractory lymphoma.

scientific article published on 10 January 2017
BeEAM (bendamustine, etoposide, cytarabine, melphalan) before autologous stem cell transplantation is safe and effective for resistant/relapsed lymphoma patients

scientific article published on 03 August 2011
Lung cancer screening with spiral CT: baseline results of the randomized DANTE trial.

scientific article published on 23 October 2007
Phase II study of asparagine-glycine-arginine-human tumor necrosis factor alpha, a selective vascular targeting agent, in previously treated patients with malignant pleural mesothelioma

scientific article published on 20 April 2010
Analysis of epidermal growth factor receptor expression as a predictive factor for response to gefitinib ('Iressa', ZD1839) in non-small-cell lung cancer

scientific article published on July 2004
Role of naive-derived T memory stem cells in T-cell reconstitution following allogeneic transplantation.

scientific article published on 5 March 2015
The management of skin reactions in cancer patients receiving epidermal growth factor receptor targeted therapies

scientific article

Paulina is supported by:

About Paulina

Help